Directorate Change

RNS Number : 7509K
Schroder Oriental Income Fund Ltd
18 December 2018
 

18 December 2018

 

Directorate Change

 

Schroder Oriental Income Fund Limited (the "Company") is pleased to announce the appointment of Kate Cornish-Bowden as an independent non-executive director of the Company. Ms Cornish-Bowden has also been appointed a member of the Audit and Risk, Nomination and Management Engagement committees.

 

Peter Rigg, chairman designate of the Company said: "I am delighted to welcome Kate to the board of the Company. She has extensive and relevant experience and I am sure that she will be able to make a valuable contribution to our work."

 

Ms Cornish-Bowden worked for 12 years as a fund manager for Morgan Stanley Investment Management, where she was managing director and head of the global equity team. Prior to Morgan Stanley she worked as a research analyst at M&G. Ms Cornish-Bowden is a non-executive Director of Finsbury Growth & Income Trust PLC, CC Japan Income & Growth Trust plc, and Calculus VCT plc, where she is chair of the audit committee, and is a former director of Scancell Holdings plc and Arcis Biotechnology Limited. Ms Cornish-Bowden is a member of the Chartered Financial Analyst Institute (CFA), holds a Masters in Business Administration (MBA), and has completed the Financial Times Non-Executive Director Diploma.

 

It is confirmed that there are no other details to be disclosed concerning Ms Cornish-Bowden under Listing Rule 9.6.13 R.

 

Ms Cornish-Bowden's appointment is effective 20 December 2018.

 

At the date of this announcement, Ms Cornish-Bowden holds no interests in the shares of the Company.

 

Enquiries:

 

Louise Richard

Schroder Investment Management Limited

Tel: 020 7658 2371


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGGGCCPUPRGRM
UK 100